OMEPRAZOLE EXTENDED
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency has awarded Contract SPE2DP26F4893 to DMS PHARMACEUTICAL GROUP INC, with a sole line item for OMEPRAZOLE EXTENDED identified by NSN 6505016247068. This award is issued under the foundational contract SPE2DX25D9900 and was posted on DIBBS on July 21, 2026, with an award date of April 22, 2026. The contract is classified as a federal award with no specified set-aside type or NAICS code, indicating it was competitively solicited without preference for small or disadvantaged businesses. The total contract value is detailed in the award documentation, and the place of performance and office address are not explicitly provided, though the agency is confirmed as the Department of Defense operating through the Defense Logistics Agency. The point of contact information is not listed, but the official UI link directs to the DIBBS award record for further reference.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(3)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
